Trius Study site #001 — Chula Vista, California

Trius Study site #001 is a clinical research site located in Chula Vista, California, United States 91911.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Trius Study site #001 has participated in 1 clinical trials.

Therapeutic areas: Skin Diseases, Infectious, Skin Diseases, Bacterial.

Sponsors: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chula Vista

Browse all research sites in California · View every site in Chula Vista

• Scripps Mercy Hospital Chula Vista
• Scripps Mercy Hospital
• Sharp Memorial Hospital
• Scripps Hospital
• University of California, San Diego - Chula Vista
• Profil Institute for Clinical Research
• Research Site
• Prosciento
• GSK Investigational Site
• GW Research
• eStudySite
• Velocity Clinical Research-Chula Vista

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trius Study site #001?

Trius Study site #001 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trius Study site #001 conducted?

Trius Study site #001 has 1 clinical trials on record. Their work covers Skin Diseases, Infectious, Skin Diseases, Bacterial.

Is Trius Study site #001 accredited by Crixeo Clinical Trials?

Trius Study site #001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trius Study site #001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.